Sun Pharmaceutical Industries - 4QFY2013 Result Review - Angel Broking

Sun Pharmaceutical reported better than expected numbers. Sun Pharma recorded 32.1% yoy growth on the sales front to end the period at Rs. 3,017cr V/s Rs. 2,800cr. The OPM came in at 41.2% (40.9% in 4QFY2013) declining by 30bp. The net profit grew by 23.3% yoy during the quarter to end the period at Rs. 1011cr (V/s Rs. 997cr expected).

We are neutral on the stock.

Source : Equity Bulls

Keywords